Gene · 85340
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Concomitant Presence of Hb Agrinio and - -Med Deletion in a Greek Male Patient with Hemoglobinopathy H: More Severe Phenotype and Literature Review. | Hematol Rep | 2023 | 37606495 | PubTator, text mining | PubMed |
| A Hemoglobin Variant Causing an Unexplained Low Oxygen Saturation by Pulse Oximetry: Two Case Reports. | Cureus | 2023 | 37602010 | PubTator, text mining | PubMed |
| Impact of Sickle Cell Disease on Affected Individuals in Nigeria: A Critical Review. | Int J Gen Med | 2023 | 37601802 | PubTator, text mining | PubMed |
| Case report: Effect of Hb E heterozygosity on HbA1c value by the Tosoh HLC-723G11. | Front Public Health | 2023 | 37601204 | PubTator, text mining | PubMed |
| Design, Synthesis, ADME, and Anticancer Studies of Newer N-Aryl-5-(3,4,5-Trifluorophenyl)-1,3,4-Oxadiazol-2-Amines: An Insight into Experimental and Theoretical Investigations. | ACS Omega | 2023 | 37593245 | PubTator, text mining | PubMed |
| Next-generation sequencing analysis of the molecular spectrum of thalassemia in Southern Jiangxi, China. | Hum Genomics | 2023 | 37592328 | PubTator, text mining | PubMed |
| Yolk sac cell atlas reveals multiorgan functions during human early development. | Science | 2023 | 37590359 | PubTator, text mining | PubMed |
| Mutational analysis of hemoglobin genes and functional characterization of detected variants, through in-silico analysis, in Pakistani beta-thalassemia major patients. | Sci Rep | 2023 | 37580329 | PubTator, text mining | PubMed |
| Protocol to identify multiple protein targets and therapeutic compounds using an in silico polypharmacological approach. | STAR Protoc | 2023 | 37561634 | PubTator, text mining | PubMed |
| Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort study. | EClinicalMedicine | 2023 | 37560260 | PubTator, text mining | PubMed |
High frequency of Lamivudine and Telbivudine resistance mutations in hepatitis B virus isolates from human immunodeficiency virus co-infected patients on highly active antiretroviral therapy in Bucaramanga, Colombia. | Front Microbiol | 2023 | 37555061 | PubTator, text mining | PubMed |
| Elevated cardiac hemoglobin expression is associated with a pro-oxidative and inflammatory environment in primary mitral regurgitation. | Free Radic Biol Med | 2023 | 37543167 | PubTator, text mining | PubMed |
| Utilization of multiple genetic methods for prenatal diagnosis of rare thalassemia variants. | Front Genet | 2023 | 37529778 | PubTator, text mining | PubMed |
Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing. | Front Genome Ed | 2023 | 37529398 | PubTator, text mining | PubMed |
| Case report: A novel 10.8-kb deletion identified in the β-globin gene through the long-read sequencing technology in a Chinese family with abnormal hemoglobin testing results. | Front Med (Lausanne) | 2023 | 37521358 | PubTator, text mining | PubMed |
| Reporting two hemoglobin J Iran cases, molecular follow-up, or is it insignificant? | Caspian J Intern Med | 2023 | 37520881 | PubTator, text mining | PubMed |
| Hb Andrew-Minneapolis Variant in a Turkish Family | Turk J Haematol | 2023 | 37519109 | PubTator, text mining | PubMed |
| Transfusion requirements and complication rate in β-thalassemia intermedia due to heterozygous β-globin gene mutation and triplicated α-globin genes. | Eur J Haematol | 2023 | 37519097 | PubTator, text mining | PubMed |
| Poly(2-ethyl-2-oxazoline)-Conjugated Hemoglobins as a Red Blood Cell Substitute. | ACS Appl Bio Mater | 2023 | 37504970 | PubTator, text mining | PubMed |
| Combination of HBA1, TTR, and SERPINF2 in plasma defines phenotype correlated with severe burn outcome. | iScience | 2023 | 37502255 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/85340/papers?page=17